SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001610618-24-000073
Filing Date
2024-05-15
Accepted
2024-05-15 16:09:06
Documents
74
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 CIDARA THERAPEUTICS, INC. FORM 10-Q cdtx-20240331.htm   iXBRL 10-Q 1251496
2 CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit3112024-03.htm EX-31.1 10378
3 CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit3122024-03.htm EX-31.2 10388
4 CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit3212024-03.htm EX-32.1 7854
5 CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit3222024-03.htm EX-32.2 7934
11 GRAPHIC cdtx-20240331_g1.jpg GRAPHIC 23028
12 GRAPHIC cdtx-20240331_g2.jpg GRAPHIC 265744
13 GRAPHIC cdtx-20240331_g3.jpg GRAPHIC 514278
14 GRAPHIC cdtx-20240331_g4.jpg GRAPHIC 404410
15 GRAPHIC cdtx-20240331_g5.jpg GRAPHIC 236884
16 GRAPHIC cdtx-20240331_g6.jpg GRAPHIC 756657
17 GRAPHIC cdtx-20240331_g7.jpg GRAPHIC 445016
18 GRAPHIC cdtx-20240331_g8.jpg GRAPHIC 581005
19 GRAPHIC cdtx-20240331_g9.jpg GRAPHIC 678635
  Complete submission text file 0001610618-24-000073.txt   15440930

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdtx-20240331.xsd EX-101.SCH 46034
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdtx-20240331_cal.xml EX-101.CAL 69494
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdtx-20240331_def.xml EX-101.DEF 264270
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdtx-20240331_lab.xml EX-101.LAB 544413
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdtx-20240331_pre.xml EX-101.PRE 398301
78 EXTRACTED XBRL INSTANCE DOCUMENT cdtx-20240331_htm.xml XML 776546
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36912 | Film No.: 24950613
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)